Medical Information
United States
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

Información selecta para pacientes y cuidadores que se encuentra disponible en Español.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

magnesium sulfate in 5% dextrose injection, USP Principal Display Panel

PRINCIPAL DISPLAY PANEL - 100 mL Bag Label

100 mL
NDC 0409-6727-55

Magnesium Sulfate
in 5% Dextrose Injection

1 g/100 mL

(10 mg/mL)

1g
TOTAL

Each 100 mL contains magnesium sulfate heptahydrate 1 g (equivalent to
8.1 mEq magnesium) and dextrose, hydrous 5 g in water for injection. May
contain sulfuric acid and/or sodium hydroxide for pH adjustment.

pH 4.5 (3.5 to 6.5)
333 mOsmol/Liter (CALC.)

Single-dose container. Discard unused portion. For intravenous use.
Recommended dosage: see prescribing information. Sterile, nonpyrogenic.
Use only if solution is clear and container is undamaged. Must not be used
in series connections.

Rx ONLY

12166-02

5
PP

Distributed by Hospira, Inc.,
Lake Forest, IL 60045 USA

Hospira

LOT:12345678

EXP:mm-yyyy

PRINCIPAL DISPLAY PANEL - 100 mL Bag Label

PRINCIPAL DISPLAY PANEL - 100 mL Bag Overwrap

100 mL
NDC 0409-6727-55

Magnesium Sulfate

in 5% Dextrose Injection, USP
1 g/100 mL (10 mg/mL)

1g
TOTAL

Each 100 mL contains magnesium sulfate heptahydrate 1 g
(equivalent to 8.1 mEq magnesium) and dextrose, hydrous 5 g in
water for injection. May contain sulfuric acid and/or sodium
hydroxide for pH adjustment.

333 mOsmol/Liter (CALC.)
pH 4.5 (3.5 to 6.5.)

DO NOT ADD SUPPLEMENTARY MEDICATION. WHENEVER
POSSIBLE USE CENTRAL ROUTE.

Single-dose container. For intravenous use. Recommended dosage:
See prescribing information. Sterile, nonpyrogenic. Use only if
solution is clear. After removing the overwrap, check for minute
leaks by squeezing container firmly. If leaks are found, discard unit
as sterility may be impaired. Must not be used in series connections.
The overwrap is a moisture barrier. Do not remove unit from
overwrap until ready for use. Use unit promptly when pouch is
opened. Store at 20 to 25°C (68 to 77°F). [See USP Controlled Room
Temperature.] Protect from freezing. See prescribing information.

Not Made With Natural Rubber Latex

Rx Only

7
OTHER

Distributed by Hospira, Inc.,
Lake Forest, IL 60045 USA

Hospira

13089-01

PRINCIPAL DISPLAY PANEL - 100 mL Bag Overwrap
Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.
Report Adverse Event